Concepedia

Miriam Moscovitch‐Lopatin

MM

Statistics

Publications

7

Citations

438

H-Index

7

Active since

1989

Affiliations

Harvard University(Current)

Beth Israel Deaconess Hospital

Beth Israel Deaconess Medical Center

Massachusetts General Hospital

Miriam Moscovitch‐Lopatin is an author at Harvard University specializing in immunology, medicine, and regulatory t cell biology.

Top concepts

Publications per year

1989–2020

7

Publications

7

IL-2 knockout recipient mice reject islet cell allografts

Jürg Steiger, Peter Nickerson, Wolfgang Steurer et al. · The Journal of Immunology · 1995 · 199 citations

Longitudinal biomarkers in amyotrophic lateral sclerosis

Fen Huang, Yuda Zhu, Jennifer Hsiao‐Nakamoto et al. · Annals of Clinical and Translational Neurology · 2020 · 108 citations · Full text

5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.

Chris Stevens, Mark L. Lipman, Steve Fabry et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 66 citations

Optimization of an HTRF Assay for the Detection of Soluble Mutant Huntingtin in Human Buffy Coats: A Potential Biomarker in Blood for Huntington Disease

Miriam Moscovitch‐Lopatin, Andreas Weiss, H. Diana Rosas et al. · PLoS Currents · 2010 · 25 citations · Full text

, , +18

An anergic, islet-infiltrating T-cell clone that suppresses murine diabetes secretes a factor that blocks interleukin 2/interleukin 4-dependent proliferation.

C Díaz-Gallo, Miriam Moscovitch‐Lopatin, Terry B. Strom et al. · Proceedings of the National Academy of Sciences · 1992 · 19 citations · Full text

, , +20

1–5 of 7